To start page

2012-5-19	+/-%	Buy	Sell	Latest	Volume	Turnover (SEK)
NVP	-3.42%	10.80	11.30	11.30	20 882	229 958.65

Home
About NeuroVive
Research & Development
Investors
Contact

Investors

Contacts
News releases
In the News
Stock
Shareholder reports
Corporate governance
Analyst coverage
Presentations
Ownership
Calendar
Financial calendar

Start / Investors / Financial calendar / Interim report January - March 2012

Interim report January - March 2012

Interim report January - March 2012

About NeuroVive
Research & Development
Investors
Contact

NeuroVive Pharmaceutical AB (publ), Biomedical Center, BMC D10, SE-221 84 Lund, Sweden

Tel: +46 (0)46 288 01 10 | Fax: +46 (0)46 888 83 48 | info@neurovive.com | Legal & Privacy